Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium
Launched by INSTITUTE OF TROPICAL MEDICINE, BELGIUM · Jun 26, 2019
Trial Information
Current as of May 28, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Skin biopsy for leishmania test requested by treating ITM clinician OR
- • externally requested skin biopsy for Leishmania tested at ITM with an ITM consultation \<7 days of the biopsy sample
- • willing and able to provide consent/assent
- • not on CL treatment
About Institute Of Tropical Medicine, Belgium
The Institute of Tropical Medicine (ITM) in Belgium is a leading research institution dedicated to advancing knowledge and practices in tropical medicine and global health. With a focus on combating infectious diseases and improving health outcomes in resource-limited settings, ITM conducts innovative clinical trials that address pressing health challenges. Leveraging a multidisciplinary approach, the institute collaborates with international partners to translate research findings into effective interventions and policies. Committed to excellence in education and research, ITM plays a pivotal role in training healthcare professionals and contributing to the global health landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antwerp, , Belgium
Patients applied
Trial Officials
Saskia van Henten, MD
Principal Investigator
Institute of Tropical Medicine
Johan van Griensven, MD,PhD
Study Director
Institute of Tropical Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials